Background Immunocompromised (IC) patients are at higher risk of severe SARS-CoV-2
infection, morbidity, and mortality compared to the general population. They should be …

Objective To compare the efficacy of covid-19 vaccines between immunocompromised and
immunocompetent people. Design Systematic review and meta-analysis. Data sources …

Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …

With the mass vaccination program for COVID-19 mRNA vaccines, there has been sufficient
real-world study (RWS) on the topic to summarize their safety in the total population and in …

Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

Background The study objective was to evaluate 2-and 3-dose coronavirus disease 2019
(COVID-19) mRNA vaccine effectiveness (VE) in preventing COVID-19 hospitalization …

Background Practical guidance is needed regarding the vaccination of coronavirus disease
2019 (COVID-19) convalescent individuals in resource-limited countries. It includes the …

This systematic review and meta-analysis was conducted to compare the safety and efficacy
of 2019 novel coronavirus disease (COVID-19) vaccines according to vaccine platform and …

Background Improved coronavirus disease 2019 (COVID-19) prevention is needed for
immunocompromised individuals. Methods A prospective study was performed of health …

Patient populations, including those with hematological malignancies, have different
responses to COVID-19 vaccines. This study aimed to quantitatively analyze the efficacy and …